MMRSA Guide
Microscopic illustration of MRSA (Staphylococcus aureus) bacteria
Live feed updated 3 days ago
MRSA Guide

What is MRSA?

MRSA (methicillin-resistant Staphylococcus aureus) is a strain of staph bacteria that has evolved resistance to the standard beta-lactam antibiotics — methicillin, oxacillin, penicillin and amoxicillin — used to treat ordinary staph infections.

The name is a mouthful, but the meaning is simple. Staphylococcus aureus — "staph" for short — is a common bacterium that lives on the skin and in the nose of roughly one in three healthy people. Most of the time it causes no problem. When it does cause infection, it is usually a boil, a wound infection, or an abscess that clears with a routine antibiotic. MRSA is the version that no longer clears with those routine antibiotics.

MRSA is a bacterium, not a virus. Antivirals such as those used for flu or COVID-19 have no effect on it. Its resistance comes from a gene called mecA, which produces an altered target protein that penicillin-family drugs cannot bind to. Decades of antibiotic use in hospitals, in the community and in livestock farming have selected for these resistant strains.

Doctors usually split MRSA into two overlapping types. Healthcare-associated MRSA (HA-MRSA) spreads in hospitals, nursing homes and dialysis units, typically via catheters, surgical wounds and shared equipment. Community-associated MRSA (CA-MRSA) spreads outside healthcare — in gyms, prisons, households and sports teams — and more often shows up as painful skin abscesses in otherwise healthy people. Read more on what MRSA looks like, how it spreads and how it is treated.

~120K
U.S. invasive infections per year
~20K
Associated deaths annually
1 in 3
People carry S. aureus on skin or nose
Quick reference

MRSA at a glance

Full name
Methicillin-resistant Staphylococcus aureus
Type
Bacterium (Gram-positive coccus) — not a virus
First identified
1961, shortly after methicillin entered clinical use
Main reservoirs
Human skin and nose; hospitals; livestock (LA-MRSA)
Main routes
Skin-to-skin contact, contaminated surfaces, shared items, indwelling devices
Resistant to
Methicillin, oxacillin, penicillin, amoxicillin and most beta-lactams
Still treatable with
Vancomycin, daptomycin, linezolid, clindamycin, doxycycline, TMP-SMX
Mortality (invasive)
Roughly 15–20% even with modern treatment
FAQ Hub

MRSA, in plain answers

Short, evidence-based answers to the questions people ask most about MRSA. Each links to a deeper guide.

The Brief · live feed

Latest on MRSA

  1. 01Jul 21, 2026
  2. 02Jul 14, 2026
  3. 03Jul 13, 2026
  4. 04Jul 13, 2026
  5. 05Jul 13, 2026
  6. 06Jul 13, 2026
  7. 07Jul 12, 2026
  8. 08Jul 12, 2026
  9. 09Jul 11, 2026
  10. 10Jul 11, 2026
  11. 11Jul 11, 2026
  12. 12Jul 10, 2026
Newsletter

The weekly MRSA briefing

One email every Thursday: the most important new research, outbreak updates, and guideline changes — distilled.